🇺🇸 FDA
Patent

US 9266843

Nuclear transport modulators and uses thereof

granted A61KA61K31/4196A61K31/454

Quick answer

US patent 9266843 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/4196, A61K31/454, A61K31/497, A61K31/5377